{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T19:39:53Z","timestamp":1787254793184,"version":"build-2736575974"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>X-linked agammaglobulinemia (XLA) is a rare primary immunodeficiency characterized by absent B cells and severe hypogammaglobulinemia. While lifelong immunoglobulin replacement therapy (IgRT) effectively prevents severe infections, it does not prevent chronic complications in a subset of patients with immune dysregulation. We report the case of a young adult with genetically confirmed XLA and severe, treatment-refractory enteropathy with persistent <jats:italic>Campylobacter jejuni<\/jats:italic> and norovirus infections, who underwent successful allogeneic hematopoietic stem cell transplantation (HSCT) after exhausting all therapeutic options. Post-transplant, the patient achieved complete resolution of chronic diarrhea, clearance of enteric pathogens, and sustained independence from parenteral nutrition, with significant improvement in nutritional status, bone density, and quality of life. This case represents one of the few documented adult XLA transplants and highlights HSCT as a feasible, safe, and potentially curative option in selected patients with severe non-hematologic complications. It underscores the need to consider HSCT earlier in the disease course, especially when organ damage is progressive and irreversible. Further studies are needed to clarify indications, timing, and cost-effectiveness of HSCT in XLA.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1662016","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T05:33:42Z","timestamp":1756791222000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Hematopoietic stem cell transplantation in an adult patient with X-linked agammaglobulinemia and severe refractory enteropathy"],"prefix":"10.3389","volume":"16","author":[{"given":"Paula Teresa","family":"L\u00f3pez-Le\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Dafne","family":"Caba\u00f1ero-Navalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Garcia-Bustos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Giner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Balastegui Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Asensi Cant\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Montoro G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Segu\u00ed-Cotano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Argente Pla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Moral Moral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12016-021-08870-5","article-title":"Agammaglobulinemia: from X-linked to autosomal forms of disease","volume":"63","author":"Cardenas-Morales","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1595069","article-title":"The contribution of BTK signaling in myeloid cells to neuroinflammation","volume":"16","author":"Bassani","year":"2025","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12016-022-08949-7","article-title":"T cell abnormalities in X-linked agammaglobulinaemia: an updated review","volume":"65","author":"Chawla","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1409111","article-title":"Editorial: IgA and mucosal immunity in vaccinology and in protection from infection","volume":"14","author":"Carsetti","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01088-2","article-title":"Haematopoietic stem cell transplant for norovirus-induced intestinal failure in X-linked agammaglobulinemia","volume":"41","author":"Shillitoe","year":"2021","journal-title":"J Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-017-0374-x","article-title":"Gastrointestinal manifestations in X-linked agammaglobulinemia","volume":"37","author":"Barmettler","year":"2017","journal-title":"J Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12884","article-title":"Chronic norovirus infection and common variable immunodeficiency","volume":"188","author":"Woodward","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1926","article-title":"Norovirus infection in primary immune deficiency","volume":"27","author":"Brown","year":"2017","journal-title":"Rev Med Virol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw497","article-title":"Nitazoxanide is an ineffective treatment of chronic norovirus in patients with X-linked agammaglobulinemia and may yield false-negative polymerase chain reaction findings in stool specimens","volume":"215","author":"Kempf","year":"2017","journal-title":"J Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2014.09.095","article-title":"Clinical usefulness of oral immunoglobulins in lung transplant recipients with norovirus gastroenteritis: a case series","volume":"46","author":"Gairard-Dory","year":"2014","journal-title":"Transplant Proc"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2024.04.015","article-title":"Clinical remission after faecal microbiota transplantation in transplanted recipients with refractory chronic Norovirus infections: a retrospective case series","volume":"30","author":"Soueges","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01551-2","article-title":"An international survey of allogeneic hematopoietic cell transplantation for X-linked agammaglobulinemia","volume":"43","author":"Nishimura","year":"2023","journal-title":"J Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13045-016-0240-y","article-title":"Allogeneic stem cell transplantation for X-linked agammaglobulinemia using reduced intensity conditioning as a model of the reconstitution of humoral immunity","volume":"9","author":"Ikegame","year":"2016","journal-title":"J Hematol Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7499\/j.issn.1008-8830.2006150","article-title":"Peripheral blood stem cell transplantation from HLA-mismatched unrelated donor or haploidentical donor for the treatment of X-linked agammaglobulinemia","volume":"22","author":"Nie","year":"2020","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00895","article-title":"Functional antibody responses following allogeneic stem cell transplantation for TP53 mutant pre-B-ALL in a patient with X-linked agammaglobulinemia","volume":"10","author":"van Zelm","year":"2019","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25554","article-title":"Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia","volume":"62","author":"Abu-Arja","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030959","article-title":"Co-occurring X-linked agammaglobulinemia and X-linked chronic granulomatous disease: two isolated pathogenic variants in one patient","volume":"11","author":"Gunderman","year":"2023","journal-title":"Biomedicines"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3389\/fimmu.2018.01826","article-title":"Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus","volume":"9","author":"Luk","year":"2018","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI128322","article-title":"Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1\u03b2-mediated colitis","volume":"130","author":"Mao","year":"2020","journal-title":"J Clin Invest"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.748284","article-title":"Bruton\u2019s tyrosine kinase supports gut mucosal immunity and commensal microbiome recognition in autoimmune arthritis","volume":"13","author":"Bonami","year":"2022","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2011.01330.x","article-title":"Elimination of norovirus in a chronic carrier under immunosuppression after heart transplanta tion\u2013effect of everolimus","volume":"24","author":"Engelen","year":"2011","journal-title":"Transpl Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2010.00565.x","article-title":"Chronic norovirus gastro enteritis in a double hematopoietic stem cell and lung transplant recipient","volume":"13","author":"Boillat Blanco","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/17562848211041004","article-title":"Systematic review with meta-analysis: encapsulated faecal microbiota transplantation - evidence for clinical efficacy","volume":"14","author":"Cold","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/idr15030025","article-title":"Modulation of the gut microbiota to control antimicrobial resistance (AMR)-A narrative review with a focus on faecal microbiota transplantation (FMT)","volume":"15","author":"Merrick","year":"2023","journal-title":"Infect Dis Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1456672","article-title":"Fecal microbiota transplantation in a patient with chronic diarrhea and primary and secondary immunodeficiency (common variable immunodeficiency and splenectomy)","volume":"14","author":"Napi\u00f3rkowska-Baran","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix252","article-title":"Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant bacteria: results of a prospective, single-center study","volume":"65","author":"Bilinski","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1016\/s0041-1345(03)00211-2","article-title":"Sirolimus: its discovery, biological properties, and mechanism of action","volume":"35","author":"Sehgal","year":"2003","journal-title":"Transplant Proc"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.06.029","article-title":"Effect of sirolimus on immune reconstitution following myeloablative allogeneic stem cell transplantation: an ancillary analysis of a randomized controlled trial comparing tacrolimus\/sirolimus and tacrolimus\/methotrexate (Blood and marrow transplant clinical trials network\/BMT CTN 0402)","volume":"25","author":"Gooptu","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.612323","article-title":"Clinical and genetic profile of X-linked agammaglobulinemia: A multicenter experience from India","volume":"11","author":"Rawat","year":"2021","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01791","article-title":"Chimerism in the realm of hematopoietic stem cell transplantation for non-malignant disorders-A perspective","volume":"11","author":"Zimmerman","year":"2020","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1527514","article-title":"Infectious outcomes of a standardized subcutaneous immunoglobulin dose reduction strategy in primary immune deficiencies amid global shortage","volume":"15","author":"Moral Moral","year":"2025","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13625","article-title":"Treosulfan-based reduced toxicity hematopoietic stem cell transplantation in X-linked agammaglobulinemia: A cost-effective alternative to long-term immunoglobulin replacement in developing countries","volume":"24","author":"Vellaichamy Swaminathan","year":"2020","journal-title":"Pediatr Transplant"},{"key":"B33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jaci.2024.03.003","article-title":"Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia","volume":"154","author":"Bahal","year":"2024","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1662016\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T05:33:44Z","timestamp":1756791224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1662016\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2025.1662016"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1662016","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"article-number":"1662016"}}